U.S was Gilead Sciences’s largest region in fiscal 2025, bringing in $20.88B of $29.44B (71%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S | $18.88B | $19.44B | $20.59B | $20.88B | |||||||||||||
| United States | — | — | — | — | |||||||||||||
| Europe | $4.47B | $4.31B | $4.63B | $5.06B | |||||||||||||
| Rest Of World | $3.93B | $3.37B | $3.53B | $3.50B | |||||||||||||
| Other International | — | — | — | — | |||||||||||||
| Other Countries | — | — | — | — | |||||||||||||
| Other European Countries | — | — | — | — | |||||||||||||
| France | — | — | — | — | |||||||||||||
| Spain | — | — | — | — | |||||||||||||
| Switzerland | — | — | — | — | |||||||||||||
| United Kingdom | — | — | — | — | |||||||||||||
| Italy | — | — | — | — | |||||||||||||
| Germany | — | — | — | — | |||||||||||||
| Japan | — | — | — | — | |||||||||||||
| Total | $27.28B | $27.12B | $28.75B | $29.44B |
Gilead Sciences brought in $29.44B from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 2.4% from $28.75B in fiscal 2024. U.S was the largest at $20.88B (70.9%), ahead of Europe at $5.06B (17.2%) and Rest Of World at $3.50B (11.9%).
Compared with fiscal 2024, Europe grew fastest, up 9.3% to $5.06B, while Rest Of World fell the most, down 0.7% to $3.50B. From fiscal 2022 to 2025, combined revenue from these regions grew from $27.28B to $29.44B, a compound annual growth rate of 2.6%. U.S's share of the total rose from 69.2% to 70.9%.
United States was Gilead Sciences’s largest region in fiscal 2008, bringing in $2.86B of $5.34B (54%).
| Geography | FY 2008 |
|---|---|
| United States | $2.86B |
| France | $395.67M |
| Other Countries | $369.05M |
| Spain | $356.61M |
| Other European Countries | $346.72M |
| United Kingdom | $297.28M |
| Italy | $277.44M |
| Germany | $242.19M |
| Switzerland | $193.31M |
| Total | $5.34B |
Gilead Sciences brought in $5.34B from its nine regions in fiscal 2008, the year ended December 31, 2008. United States was the largest at $2.86B (53.6%), ahead of France at $395.67M (7.4%) and Other Countries at $369.05M (6.9%). The other six regions brought in $1.71B combined.
Gilead Sciences (GILD) reports its revenue by geography. In fiscal 2025, U.S was its largest region, bringing in $20.88B (70.9% of the total), followed by Europe at $5.06B (17.2%).
U.S was Gilead Sciences' largest region in fiscal 2025, bringing in $20.88B, or 70.9% of the $29.44B total across its three regions.
Among Gilead Sciences' regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 9.3% from $4.63B to $5.06B.
Every figure comes from Gilead Sciences' annual financial filings, as reported. Each line keeps the name Gilead Sciences gives it, and years follow its fiscal calendar.
Gilead Sciences' revenue by geography goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.